The expanding use of GnRH antagonist protocols has enabled the use of a GnRH agonist as the trigger for final oocyte maturation. A GnRH agonist trigger clearly cannot be employed in a GnRH agonist ...

GnRH agonists can delay the bone age advancement and subsequently improve the final adult height. Method: Sixty eight girls with central precocious puberty and early puberty with a mean age of 9 ...

Abbott and Neurocrine Biosciences have entered into a collaboration to develop and commercialize elagolix, a gonadotropin-releasing hormone (GnRH) antagonist that has recently completed a Phase ...

Increasingly since the early 1990s GnRH antagonist protocols have been used, which also prevent the LH surge but without the initial flare. Antagonist and agonist protocols in in vitro ...